CHM chimeric therapeutics limited

0.00%

0.4¢

Ann: Positive in vitro data for CHM 1301 CAR NK cells, page-68

First 68 Last

Share
Profile

Follow
slick

15,713 Posts.

8780

23/11/23

21:24

Post #: 71078542
Share

Originally posted by Steini: ↑

Rythex, you know that's the problem with charts.

"... This ugly top left bottom right looking chart - With over 80% of the shareholder value wiped since listing..." is as accurate as the past and failed 3 times to predict a 30-40% spike in the past few weeks.

If you just invest based on charts alone you either never or always buy or will always sit on the sidelines watching as on any given day the chart predicts either up, staying the same or down.

Today's anns was never meant to be a game changer, more a confirmation that CHM's next gen CAR-T 1101, now called CHM1301 can be used to treat other SOLID cancers too. The big announcements recently were the CHM 1101 GMB Ph1 read out and the CDH 17 IND. 2 years ago those would have taken the sp to $1. These days any non-income tech stock is valued at ZERO regardless of asset-development and cash at hand.

Regardless of how many shares will be issued and cash received the EV would be less than $ 10m if the sp stays at the 3c level. But as soon as CHM turns the current "quick" Ph1b into a pivotal / registrational trial - already foreshadowed by the FDA - the big guys will notice and trying to get their hands on it. At this stage nobody can beat CHM when it comes to GBM treatments and that alone is worth more than just AUD 10m.

Did I mention that CHM and IMU are the only ASX listed companies having clinical trials underway using different types of CAR-T. And do you know that CHM's CEO has been among the few scientists in the world who participated developing CD 19 - CAR-Ts?

Not sure if the charts can tell you that.

GLTA

Expand

Totally agree with this. I’ve tried and failed twice here. That’s not a negative to the company, it’s just the way it trades and how important liquidity is in successful charting. IMO.

Cheers all, sincerely hope this one works out.

CHM Price at posting: 3.1¢ Sentiment: None Disclosure: Not Held
7 Upvote

1 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

PIQ

Proteomics notches up as company launches PromarkerD into the US

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

First 68 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $8.060M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.4¢	$28.14K	7.037M

Buyers (Bids)

No.	Vol.	Price($)
1	243067	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	14771167	22

View Market Depth

No.	Vol.	Price($)
1	243067	0.004
39	25597272	0.003
14	13250506	0.002
10	50600000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	14771167	22
0.006	13177711	13
0.007	3200000	3
0.008	8542434	6
0.009	2327672	4

Last trade - 15.39pm 20/06/2025 (20 minute delay)

CHM (ASX) Chart

Ann: Positive in vitro data for CHM 1301 CAR NK cells, page-68

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Proteomics notches up as company launches PromarkerD into the US

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Positive in vitro data for CHM 1301 CAR NK cells, page-68

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Proteomics notches up as company launches PromarkerD into the US

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News